Neoadjuvant Chemotherapy for Borderline Resectable Head and Neck Cancers: A Comparative Study of Three-Drug and Two-Drug Regimens in a Low- and Middle-Income Country (LMIC) Context.

Cureus · 2024 · PMC11531341 · PMID 39493147

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although the TPF regimen showed a trend toward improved OS and PFS, the difference was not statistically significant.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

The overall survival and progression-free survival were improved in the TPF group, although the study did not reach statistical significance in these endpoints due to the limited sample size.

also in 111,027 other papers

an overall trendno p-value reported

The TPF regimen showed a significantly higher conversion to operability and an overall trend toward improved progression-free and overall survival.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.